ICU Medical Inc. (NASDAQ:ICUI) – Equities researchers at Roth Capital increased their Q3 2016 earnings estimates for ICU Medical in a research report issued to clients and investors on Thursday. Roth Capital analyst C. Lewis now expects that the firm will post earnings per share of $1.01 for the quarter, up from their previous estimate of $0.93. Roth Capital also issued estimates for ICU Medical’s Q4 2016 earnings at $0.95 EPS, FY2016 earnings at $3.90 EPS, Q3 2017 earnings at $1.08 EPS and FY2017 earnings at $4.21 EPS.

ICUI has been the topic of a number of other reports. Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 price objective on the stock in a research note on Friday, August 12th. Piper Jaffray Cos. reiterated a “neutral” rating and issued a $119.00 target price (up from $115.00) on shares of ICU Medical in a report on Thursday, August 11th.

Earnings History and Estimates for ICU Medical (NASDAQ:ICUI)

Shares of ICU Medical (NASDAQ:ICUI) opened at 149.97 on Monday. ICU Medical has a one year low of $85.56 and a one year high of $152.67. The company has a 50-day moving average of $126.86 and a 200-day moving average of $113.00. The company has a market capitalization of $2.42 billion, a PE ratio of 44.66 and a beta of 0.37.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Monday, August 8th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.10. The firm earned $96.70 million during the quarter, compared to analysts’ expectations of $89.66 million. ICU Medical had a net margin of 14.94% and a return on equity of 10.33%. ICU Medical’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.97 earnings per share.

In related news, CFO Scott E. Lamb sold 1,474 shares of the firm’s stock in a transaction on Tuesday, September 13th. The shares were sold at an average price of $121.61, for a total transaction of $179,253.14. Following the sale, the chief financial officer now directly owns 4,705 shares in the company, valued at $572,175.05. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Richard Md Sherman sold 1,500 shares of the firm’s stock in a transaction on Thursday, October 6th. The stock was sold at an average price of $140.60, for a total transaction of $210,900.00. Following the sale, the director now owns 70,699 shares in the company, valued at $9,940,279.40. The disclosure for this sale can be found here. Corporate insiders own 15.90% of the company’s stock.

Several large investors have recently modified their holdings of the company. Tower Research Capital LLC TRC bought a new stake in shares of ICU Medical during the second quarter worth approximately $124,000. Bank of Montreal Can bought a new stake in shares of ICU Medical during the second quarter worth approximately $133,000. PineBridge Investments L.P. raised its stake in shares of ICU Medical by 3.6% in the second quarter. PineBridge Investments L.P. now owns 1,835 shares of the company’s stock worth $207,000 after buying an additional 63 shares during the last quarter. Amalgamated Bank bought a new stake in shares of ICU Medical during the second quarter worth approximately $214,000. Finally, M&T Bank Corp raised its stake in shares of ICU Medical by 3.3% in the first quarter. M&T Bank Corp now owns 2,117 shares of the company’s stock worth $220,000 after buying an additional 67 shares during the last quarter. Institutional investors and hedge funds own 89.52% of the company’s stock.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

5 Day Chart for NASDAQ:ICUI

Receive News & Stock Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related stocks with our FREE daily email newsletter.